Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis

Journal of Nutrigenetics and Nutrigenomics

Volumn 4, Issue 1, 2011, Pages 12-24

  Merched, Aksam J ^a,d   Serhan, Charles N ^b   Chan, Lawrence ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d Bordeaux Segalen University   (France)

Author keywords

Hyperlipidemia; Inflammation; Lipoxins; Lipoxygenase; Resolution

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; LIPOXIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE DISRUPTION; GENE OVEREXPRESSION; HOMEOSTASIS; HYPERLIPIDEMIA; INFLAMMATION; LIPID DIET; LIPOGENESIS; MOUSE; NONHUMAN; NUTRIGENOMICS; PRIORITY JOURNAL;

MURINAE; MUS;

EID: 79953706626     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000326890     Document Type: Article

References (42)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
2. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874. (Pubitemid 36019640)
3. Chiang N, Arita M, Serhan CN: Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 2005;73:163-177. (Pubitemid 41253473)
4. Serhan CN: Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1994;1212:1-25. (Pubitemid 24123884)
5. Serhan CN: Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002;68-69:433-455. (Pubitemid 35247413)
6. Serhan CN, Yacoubian S, Yang R: Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008;3:279-312. (Pubitemid 351488283)
7. Bocan TM, Rosebury WS, Mueller SB, Kuchera S, Welch K, Daugherty A, Cornicelli JA: A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 1998;136:203-216. (Pubitemid 28133408)
8. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD: Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation 2001;103:2277-2282. (Pubitemid 32433718)
9. George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D: 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 2001;104:1646-1650. (Pubitemid 32947528)
10. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, Sigal E: Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000;20:2100-2105.
11. Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, Srinivasan S, Hedrick CC, Pratico D, Witztum JL, Nadler JL, Funk CD, Ley K: Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;110:2024-2031. (Pubitemid 39331917)
12. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ: Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 2002;91:120-126. (Pubitemid 34827222)
13. Reilly KB, Srinivasan S, Hatley ME, Patricia MK, Lannigan J, Bolick DT, Vandenhoff G, Pei H, Natarajan R, Nadler JL, Hedrick CC: 12/15-Lipoxygenase activity mediates inflammatory monocyte/endothelial interactions and atherosclerosis in vivo. J Biol Chem 2004;279:9440-9450. (Pubitemid 38296011)
14. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kuhn H, Guevara NV, Chan L: Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996;98:2201-2208. (Pubitemid 26394192)
15. Sun D, Funk CD: Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 1996;271:24055-24062. (Pubitemid 26327385)
16. Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, Huang L, Cui J, Rader DJ, Evans JF, Habenicht AJ, Funk CD: The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemiadependent aortic aneurysm. Nat Med 2004;10:966-973. (Pubitemid 39273738)
17. Chisolm GM, Steinberg D: The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815-1826. (Pubitemid 30628668)
18. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE: Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171:6856-6865. (Pubitemid 37532121)
19. Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L: Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 2008;22:3595-3606.
20. Tabas I: Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010;10:36-46.
21. Merched AJ, Chan L: Atherosclerosis in experimental animal models; in Serhan CN, Ward PA, Gilroy DW (eds): Fundamentals of Inflammation. New York, Cambridge University Press, 2010, pp 426-431.
22. Merched AJ, Williams E, Chan L: Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol 2003;23:1608-1614. (Pubitemid 37108205)
23. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L: Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003;107:2726-2732. (Pubitemid 36667248)
24. Chen KH, Reece LM, Leary JF: Mitochondrial glutathione modulates TNF-α-induced endothelial cell dysfunction. Free Radic Biol Med 1999;27:100-109. (Pubitemid 29353090)
25. Merched AJ, Chan L: Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation 2004;110:3830-3841. (Pubitemid 40023982)
26. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3: RESEARCH0034.
27. 4 stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelia l interactions. Blood 1999;94:4132-4142.
28. 4 and related compounds: development of new extraction techniques for lipoxins. Lab Invest 2002;82:1253-1254. (Pubitemid 35014859)
29. Zhao L, Cuff CA, Moss E, Wille U, Cyrus T, Klein EA, Pratico D, Rader DJ, Hunter CA, Pure E, Funk CD: Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 2002;277:35350-35356.
30. Aliberti J, Hieny S, Reise Sousa C, Serhan CN, Sher A: Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002;3:76-82. (Pubitemid 34065621)
31. 4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med 2002;196:1253-1262. (Pubitemid 35304190)
32. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol 2005;6:1191-1197. (Pubitemid 43045627)
33. Lawrence T, Willoughby DA, Gilroy DW: Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002;2:787-795. (Pubitemid 37328718)
34. Miller YI, Worrall DS, Funk CD, Feramisco JR, Witztum JL: Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol Biol Cell 2003;14:4196-4206. (Pubitemid 37186320)
35. Fadok VA, Chimini G: The phagocytosis of apoptotic cells. Semin Immunol 2001;13:365-372. (Pubitemid 33121962)
36. Kuhn H, O'Donnell VB: Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 2006;45:334-356. (Pubitemid 43818131)
37. Weibel GL, Joshi MR, Alexander ET, Zhu P, Blair IA, Rothblat GH: Overexpression of human 15 (S)-lipoxygenase-1 in R AW macrophages leads to increased cholesterol mobilization and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2009;29:837-842.
38. Assimes TL, Knowles JW, Priest JR, Basu A, Borchert A, Volcik KA, Grove ML, Tabor HK, Southwick A, Tabibiazar R, Sidney S, Boerwinkle E, Go AS, Iribarren C, Hlatky MA, Fortmann SP, Myers RM, Kuhn H, Risch N, Quertermous T: A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis 2008;198:136-144. (Pubitemid 351406358)
39. Hersberger M, Muller M, Marti-Jaun J, Heid IM, Coassin S, Young TF, Waechter V, Hengstenberg C, Meisinger C, Peters A, Konig W, Holmer S, Schunkert H, Klopp N, Kronenberg F, Illig T: No association of two functional polymor phisms in human ALOX15 with myocardial infarction. Atherosclerosis 2009;205:192-196.
40. Wittwer J, Bayer M, Mosandl A, Muntwyler J, Hersberger M: The c.-292C > T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective. Clin Chem Lab Med 2007;45:487-492. (Pubitemid 46632223)
41. Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H: Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr 2008;88:934-940.
42. Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD, Yang Z, Smith KM, Wu R, Bevard MH, Garmey JC, Nadler JL: 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am J Physiol Endocrinol Metab 2008;295: E1065-E1075.